GCM
OGN icon

Gladius Capital Management’s Organon & Co OGN Stock Holding History

Gladius Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,456
Closed -$27.9K – 196
2024
Q3 		$27.9K Sell
1,456
-81
-5% -$1.68K ﹤0.01% 243
2024
Q2 		$31.8K Sell
1,537
-530
-26% -$10.5K ﹤0.01% 230
2024
Q1 		$38.9K Sell
2,067
-109
-5% -$1.87K 0.01% 223
2023
Q4 		$31.4K Buy
2,176
+858
+65% +$11.7K ﹤0.01% 273
2023
Q3 		$22.9K Sell
1,318
-55
-4% -$1.15K ﹤0.01% 334
2023
Q2 		$28.6K Buy
1,373
+178
+15% +$3.87K ﹤0.01% 265
2023
Q1 		$28.1K Sell
1,195
-229
-16% -$6.15K ﹤0.01% 296
2022
Q4 		$39.8K Buy
1,424
+178
+14% +$4.55K ﹤0.01% 224
2022
Q3 		$30K Buy
+1,246
New +$37.6K ﹤0.01% 309

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gladius Capital Management's OGN Position: Q4 2024 in Review

Gladius Capital Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 1,456 shares — an estimated $27.9K sold.

Gladius Capital Management first reported a position in OGN in Q3 2022 and held it in 9 quarters. The position peaked at $39.8K in Q4 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Gladius Capital Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,456 Organon & Co shares in Q4 2024, an estimated $27.9K.
  • Gladius Capital Management first reported a position in Organon & Co in Q3 2022 and held it in 9 quarters.
  • Gladius Capital Management's Organon & Co position peaked at $39.8K in Q4 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.